ArticleQuantitative imaging in medicine and surgery2025
Prognostic significance of cold pressor test myocardial perfusion imaging in patients with ischemia and nonobstructive coronary arteries.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Correspondence to: Cunzhi Lu, MD. Department of Nuclear Medicine, Xuzhou Central Hospital, No. 199, Jiefangnan Road, Xuzhou 221009, China. Email: 13912045900@163.com; Yuetao Wang, MD. Department of Nuclear Medicine, The Third Affiliated Hospital of Soochow University, No. 185, Juqian Street, Changzhou 213003, China; Institute of Clinical Translation of Nuclear Medicine and Molecular Imaging, Soochow University, Changzhou, China. Email: yuetao-w@163.com. Background: Ischemia with nonobstructive coronary arteries (INOCA) is prevalent among patients with angina, is linked to major adverse cardiovascular events (MACEs), and is often driven by endothelial dysfunction. This study aimed to assess the efficacy of the cold pressor test (CPT) in identifying individuals at elevated risk for MACEs among patients with INOCA. Methods: A total of 124 INOCA inpatients were included in the retrospective cohort study. Clinical data including age, gender, BMI, hypertension, hyperlipidemia, diabetes mellitus (DM), active smoking, and symptoms were collected from medical records. A positive CPT-myocardial perfusion imaging (MPI) result was considered to be the presence of a reversible perfusion defect with a summed difference score (SDS) ≥2. The patients were routinely followed-up according to standard protocol. An MACE was defined as a composite endpoint including all-cause mortality, late coronary revascularization [≥3 months following single-photon emission computed tomography (SPECT)-MPI], nonfatal myocardial infarction, rehospitalization due to angina, heart failure, and stroke. Results: The number of positive CPT-MPI cases was 49 (39.5%) and that of negative CPT-MPI cases was 75 (60.5%). Compared with negative CPT-MPI, positive CPT-MPI group had a higher percentage of DM [16 (32.7%) Conclusions: Among patients with INOCA <39.5% had positive CPT, which was significantly related to MACE occurrence. In patients with positive CPT, the risk of MACE increased twofold. Coronary atherosclerosis was the independent risk factor of positive CPT. CPT-MPI offers valuable insights for risk stratification and treatment decision-making in patients with INOCA, particularly in identifying those at higher risk of adverse cardiovascular events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.